In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation
May 6th, 2020
Presented here is a protocol to perform genetic manipulation in the embryonic ferret brain using in utero electroporation. This method allows for targeting of neural progenitor cells in the neocortex in vivo.
This protocol allows us to perform a genetic manipulation in vivo in a key animal model that allows us to study the expansion and folding of a developing neocortex. The main advantage of this method is in using high spatial and temporal specificity in targeting those neural stem cells that are the key cell type for brain development. Before beginning the procedure, pull glass capillaries on a micro pipette puller and use forceps to cut off the distal part of the capillary to adjust the diameter of the capillary tip.
On embryonic day 33, add the appropriate concentration of DNA in PBS, supplemented with 0.1%Fast Green with gentle mixing, and place a 3-hour-fasted, anesthetized, pregnant female ferret on an operation table with a heat pad. Confirm the appropriate level of sedation by touching the periocular skin and pinching the skin between the second and third or third and fourth toes of both hind limbs. Isoflurane can cause adverse effects, including nausea and dizziness.
When handling isoflurane in liquid form, use the protective equipment. During the surgery, use appropriate canisters to capture the gas. Inject the animal subcutaneously with analgesic, antibiotic, and glucose, and place ointment on the animal's eyes.
Use clippers to shave the abdomen, and clean the exposed skin with a water, soap, and iodine solution. Then, dry the skin with gauze swabs and disinfect with alcohol and iodine scrubs. For in utero electroporation, place a sterile drape over the animal and use a scalpel to make an approximately 5-centimeter skin incision at the linea alba.
Use scissors to cut through the muscle layer and place gauze swabs around the incision site. Wet the gauze with PBS and place the uterus onto the swabs. Using a pipette with a long tip, load one of the pulled glass capillaries with 5 microliters of DNA solution per embryo to be injected.
Attach the loaded capillary to a holder and connect the other side of the holder to a tube and a mouthpiece. Locate the head of the first embryo and place a fiber optic light source next to the head. Using the pigmented iris as a reference point, penetrate the skin, skull, and cerebral tissue with the tip of the glass capillary and use mouth pipetting to facilitate the delivery of 3-5 microliters of the injection solution into the ventricle of one of the cerebral hemispheres.
Because the injected solution contains 0.1%Fast Green, a successful injection will result in a dark green staining of the injected ventricle, which will now be visible as a kidney-shaped structure. After the injection, place the tweezer electrodes on the uterus above the head of the embryo with the positive pole above the area to be targeted and the negative pole below the injected area. Set the pulse length of the electroporate to 50 milliseconds, the pulse voltage to 100 volts, the pulse interval to one second, and the number of pulses to five.
When all of the parameters have been set, press Pulse"and quickly drop several drops of warm PBS onto the electroporated embryo. When all of the embryos have been electroporated, return the uterus to the peritoneal cavity and use a 4-0 suture to close the muscle layer with the peritoneum. Close the skin in a similar manner and cover the wound with aluminum spray.
Then return the animal to its cage with a heat source and monitoring until full recumbency. Four days after electroporation at embryonic day 37, most of the targeted cells and their progeny are still in the germinal zones and the cells are seldom observed further basally within the cortical plate. The progenitor identity can be examined by immunofluoresence for markers of cycling cells, such as PCNA, whereas a subset of progenitors undergoing mitosis can be shown by markers such as phospho-histone 3.
At post-natal day zero, eight days after electroporation, the progeny of the targeted cells spread to all of the histological layers. Using a combination of transcription factor markers, different basal progenitor populations can be revealed. For example, Sox2 is a marker of proliferative progenitor cells, including basal radial glia.
And T-box brain protein 2 is a marker of neurogenic basal progenitors, which are mainly intermediate progenitors. By post-natal day 16, a majority of the targeted cells stop dividing and differentiate into neurons and glia, with ferret post-natal day 16 neocortex exhibiting the characteristic folding pattern. The in utero electroporation of ferret embryos is an extremely powerful method to study the function of genes.
It has allowed us to study genes that have been implicated in the expansion of the neocortex in evolution, including human-specific genes. And using this powerful method, we have indeed been able to find out key features of how the evolutionary expansion of the human neocortex likely worked.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a protocol for genetic manipulation in the embryonic ferret brain using in utero electroporation. The method focuses on targeting neural progenitor cells in vivo within the developing neocortex, providing insights into brain development mechanisms.
Key Study Components
Area of Science
- Neuroscience
- Developmental Biology
- Genetic Manipulation
Background
- In utero electroporation allows precision targeting of neural stem cells.
- The ferret is a key model for studying neocortex expansion and folding.
- This method enhances understanding of the developmental processes in the brain.
- Previous studies have explored evolutionary gene functions using this approach.
Purpose of Study
- To develop a reliable method for genetic manipulation in the embryonic ferret brain.
- To investigate the roles of specific genes in neocortical development.
- To understand the expansion and folding mechanisms of the neocortex.
Methods Used
- In vivo electroporation is performed on embryonic ferrets.
- DNA solution is injected into the cerebral ventricles of 33-day-old embryos.
- Five electrical pulses are applied to facilitate gene expression at targeted sites.
- Key steps include anesthesia, incision, and careful administration of the DNA solution.
- Following electroporation, various molecular markers are used to analyze targeted cells.
Main Results
- Postnatal analysis shows targeted cells differentiate into neurons and glia.
- Gene expression in progenitor cells can be tracked using transcription factor markers.
- Significant findings include the identification of key genes related to neocortex expansion.
Conclusions
- This method opens avenues for studying gene functions in brain development.
- Findings have implications for understanding evolution of the human neocortex.
- The electroporation technique enables targeted manipulation of gene expression during critical developmental phases.
Frequently Asked Questions
Executive Industry Relevance
In utero electroporation in the ferret neocortex enables precise genetic manipulation of neural progenitor cells during critical developmental windows, supporting mechanistic de-risking in neurodevelopmental target validation. This approach provides a translationally relevant model for interrogating gene function in a system with anatomical and cellular features closer to primates than rodents. The method enhances predictive confidence for early-stage neuroscience portfolios by bridging discovery biology and preclinical model relevance.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional interrogation of candidate genes in a disease-relevant, gyrencephalic brain model.
- Supports mechanistic de-risking by clarifying gene roles in neural progenitor proliferation and differentiation.
- Facilitates target validation through spatiotemporal control of gene expression in vivo.
Screening & Assay Development
- Prepares validated neural progenitor systems for downstream phenotypic and molecular assays.
- Enables reproducible manipulation and tracking of cell fate using quantitative molecular markers.
- Supports assay standardization by allowing consistent targeting and readout of neural cell populations.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by modeling human-like neocortical development.
- Provides continuity from gene discovery to preclinical validation in a system with higher predictive value than rodent models.
- De-risks advancement decisions by enabling direct observation of gene effects on cortical structure and cell lineage.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling hypothesis-driven gene manipulation, phenotypic screening, and mechanistic validation in a translationally relevant model.
- Discovery Biology: Supports hypothesis testing and pathway clarification for neurodevelopmental targets.
- Screening: Delivers reproducible, quantitative outputs for cell identity and lineage tracking.
- Analytics: Provides molecular and histological readouts for comparative analysis across conditions and timepoints.
- Translational Research: Bridges rodent and primate models by leveraging ferret neocortex features relevant to human brain development.
- Enterprise Reuse: Establishes a reusable platform for gene function studies and target validation in neurodevelopmental research.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neurodevelopmental target validation.
- Operational Value: Enables standardized, scalable manipulation of neural progenitors with high spatial and temporal specificity.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing translationally relevant data early in the pipeline.
- Portfolio Impact: Supports risk-adjusted prioritization of neuroscience assets by clarifying gene function in a human-relevant context.
Implementation Considerations
- Requires expertise in embryonic surgery, in utero electroporation, and neurodevelopmental biology.
- Demands specialized instrumentation for microinjection, electroporation, and molecular analysis.
- Necessitates cross-team standardization of protocols and analytical endpoints.
- Adaptation to other species or developmental stages may require protocol optimization.
- Practical limitations include technical complexity and the need for precise timing and targeting.
